% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Tikk:136820,
author = {K. Tikk$^*$ and K. Weigl$^*$ and M. Hoffmeister$^*$ and S.
Igel and M. Schwab and J. Hampe and S. J. Klug and U.
Mansmann and F. Kolligs and H. Brenner$^*$},
title = {{S}tudy protocol of the {R}a{PS} study: novel risk adapted
prevention strategies for people with a family history of
colorectal cancer.},
journal = {BMC cancer},
volume = {18},
number = {1},
issn = {1471-2407},
address = {London},
publisher = {BioMed Central},
reportid = {DKFZ-2018-01258},
pages = {720},
year = {2018},
abstract = {People aged 40-60 years with a family history (FH) of
colorectal cancer (CRC) in 1st degree relatives (FDRs) have
a 2- to 4-fold increased risk of CRC compared to the average
risk population. Therefore, experts recommend starting CRC
screening earlier for this high-risk group. However,
information on prevalence of relevant colonoscopic findings
in this group is sparse, and no risk adapted screening
offers are implemented in the German health care system. For
example, screening colonoscopy is uniformly offered from age
55 on, regardless of family history. Thus, we initiated a
multicenter epidemiological study - the RaPS study (Risk
adapted prevention strategies for colorectal cancer) - with
the following aims: to determine the prevalence of having a
FH of CRC in FDR in the German population aged 40-54 years;
to investigate the prevalence of colorectal neoplasms among
people with a FDR; and to develop risk-adapted prevention
strategies for this high-risk group based on the collected
information.A random sample of 160.000 persons from the
general population aged 40-54 years from the catchment
areas of three study centers in Germany (Dresden, Munich and
Stuttgart) are contacted to assess FH of CRC by an
online-questionnaire. Those with a FH of CRC in FDRs are
invited to the study centers for individual consultation
regarding CRC prevention. Participants are asked to donate
blood and stool samples and medical records of colonoscopies
will be obtained. Prevalence of CRC and its precursors will
be evaluated. Furthermore, genetic, epigenetic and proteomic
biomarkers in blood and microbiomic biomarkers in stool will
be investigated. Risk markers and their eligibility for risk
adapted screening offers will be examined.This study will
provide data on the prevalence of colorectal neoplasms among
persons with a FH of CRC in the age group 40-54 years,
which will enable us to derive evidence based screening
strategies for this high-risk group.This trial was
registered retrospectively in the German Clinical Trials
Register (DRKS) on 29th of December 2016: German Clinical
Trials Register DRKS-ID: DRKS00007842 .},
cin = {C070 / L101 / G110},
ddc = {610},
cid = {I:(DE-He78)C070-20160331 / I:(DE-He78)L101-20160331 /
I:(DE-He78)G110-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:29976178},
pmc = {pmc:PMC6034214},
doi = {10.1186/s12885-018-4646-5},
url = {https://inrepo02.dkfz.de/record/136820},
}